Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp

Bullboard Posts

Comment by Sir_Holleron Aug 08, 2015 2:41pm

119 Views

Post# 24000484

RE:What you don't understand...

"Is the optic's show, for those that understand, is D&G tried to transfer all their holdings to a "diversified" health care fund after raising 67 million. WHY?"

Dalson and Green specialize in from concept to start-up businesses(eg., PHM, CVX, LND). With PHM having a market cap of hundreds-of-millions and past the concept to start-up stage it was time for them to put a solid operations team in for expansion. This is what should happen according to Hodson.

Dalsin and Greene were selling their PHM shares and taking their payday as they completed their task and were handing off PHM to the new management. The new management bought PHM shares in a big way given their shareholdings through the Sleep Management acquisition. Greene and Dalsin let the new team takeover management responsibilities. Dalsin and Greene didn't just sell PHM and leave. It was a handoff as PHM is in its next phase of development. Dalsin and Greene are still involved and have a funancial interest. The new team came in and took a major stake. At Sleep Management the new team had a proven track record and were growing Sleep Management at a rate of 100% year-over-year through organic growth. With Sleep Management now representing half of PHM's EBITDA they will continue with their work with the bigger platform adding a new dimension to PHM beyond cross-selling, organic growth. The new management also says they've identified additional cross-selling opportunities and have reaffirmed PHM's year-end exit targets including through acquisitions.

The new fund is going to back Dalsin's and Green's new concept and start-up opportunities and keep control of them until a more mature stage instead of letting the public make all the early money as they did in PHM.

~